Yahoo · Oct 30, 2026
Gerresheimer revenue rises 8% in Q3 on demand for drug delivery devices
Investing.com -- Gerresheimer reported third-quarter revenue of €605 million, up 8% year-over-year, while adjusted EBITDA came in at €103 million, down 2.8% YoY, with the adjusted EBITDA margin at 17.1% compared to 19.0% in the prior-year quarter.

